# ![@archer_coa Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::69558522.png) @archer_coa chris

chris posts on X about $sprb, $prtc, in the, market the most. They currently have [---] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::69558522/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::69558522/c:line/m:interactions.svg)

- [--] Week [---] -76%
- [--] Month [-----] +186%
- [--] Months [------] +2,996%
- [--] Year [------] -28%

### Mentions: [--] [#](/creator/twitter::69558522/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::69558522/c:line/m:posts_active.svg)

- [--] Month [--] -33%
- [--] Months [--] +440%
- [--] Year [--] -38%

### Followers: [---] [#](/creator/twitter::69558522/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::69558522/c:line/m:followers.svg)

- [--] Week [---] +0.67%
- [--] Month [---] +4.30%
- [--] Months [---] +11%
- [--] Year [---] +13%

### CreatorRank: [---------] [#](/creator/twitter::69558522/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::69558522/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [cryptocurrencies](/list/cryptocurrencies)  [currencies](/list/currencies)  [technology brands](/list/technology-brands)  [exchanges](/list/exchanges)  [travel destinations](/list/travel-destinations)  [countries](/list/countries)  [automotive brands](/list/automotive-brands) 

**Social topic influence**
[$sprb](/topic/$sprb) #18, [$prtc](/topic/$prtc), [in the](/topic/in-the), [market](/topic/market), [health](/topic/health), [market cap](/topic/market-cap), [unizen](/topic/unizen), [$160m](/topic/$160m), [priority](/topic/priority), [nasdaq](/topic/nasdaq)

**Top accounts mentioned or mentioned by**
[@unizenio](/creator/undefined) [@geneinvesting](/creator/undefined) [@invacio](/creator/undefined) [@daphnezohar](/creator/undefined) [@puretechh](/creator/undefined) [@bharringtonw11](/creator/undefined) [@williamjdwest](/creator/undefined) [@barryblockchain](/creator/undefined) [@mginvestor](/creator/undefined) [@ellenolenska](/creator/undefined) [@teslanomous](/creator/undefined) [@seandentbsc](/creator/undefined) [@pmac295](/creator/undefined) [@mikedrop13](/creator/undefined) [@thedark66840057](/creator/undefined) [@rogerbakeruk](/creator/undefined) [@conormcmorrow](/creator/undefined) [@leovaradkar](/creator/undefined) [@ronwitteles](/creator/undefined) [@deepvalueinv](/creator/undefined)

**Top assets mentioned**
[Spruce Biosciences, Inc. (SPRB)](/topic/$sprb) [Unizen (ZCX)](/topic/unizen) [Uber Technologies, Inc. (UBER)](/topic/$uber) [Day One Biopharmaceuticals, Inc. (DAWN)](/topic/$dawn) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Jazz Pharmaceuticals, Inc. (JAZZ)](/topic/$jazz) [AbbVie Inc (ABBV)](/topic/$abbv) [??Holder (BNBHOLDER)](/topic/holder)
### Top Social Posts
Top posts by engagements in the last [--] hours

"@MikeDrop13 @blokeinwa @TheDark66840057 @Invacio Exactly correct. They raised money on the back of false claims lies and deception. Its been nearly a year since the WP release. Products are built and ready to roll out they said. 🙈🙈🙈🙈"  
[X Link](https://x.com/archer_coa/status/1061575853623123968)  2018-11-11T11:06Z [---] followers, [--] engagements


"@ellen_olenska_ @williamjdwest @Invacio What ever happened to those thousands of PS3s"  
[X Link](https://x.com/archer_coa/status/1064784924098600960)  2018-11-20T07:38Z [---] followers, [--] engagements


"@ellen_olenska_ @williamjdwest @Invacio Invacio bring lies and deluded ramblings from William West nothing more"  
[X Link](https://x.com/archer_coa/status/1066081335637417984)  2018-11-23T21:29Z [---] followers, [--] engagements


"@ellen_olenska_ @CryptoScatman @MikeDrop13 @williamjdwest @Invacio @Laice1 @trending_crypt @cryptopig3 @Crypto_Dummie @necromage93 @RogerBakerUK @officiallykeith @TheDark66840057 @FudderJust Excellent research here providing irrefutable evidence to quash more of Wests lies. https://m.youtube.com/watchv=YzlBq9jXlog https://m.youtube.com/watchv=YzlBq9jXlog"  
[X Link](https://x.com/archer_coa/status/1067385919274213377)  2018-11-27T11:53Z [---] followers, [--] engagements


"@linc_steffens @Invacio @williamjdwest @RogerBakerUK Those who got defrauded by Invacio I would encourage you to make a claim against West in the UK courts to recover your loses. West has pierced the corporate veil due to this fraud. This means you can go after West directly and not Invacio"  
[X Link](https://x.com/archer_coa/status/1074684125448151040)  2018-12-17T15:13Z [---] followers, [--] engagements


"@MonTT2002 @quiquepepe @Femi_Sorry We are Europes leading defence and intelligence power and absorb 354bn per year in EU exports. The Americans are not stupid they can see this. Its no surprise they are ready to jump in to the vacuum by offering a fast tracked trade deal"  
[X Link](https://x.com/archer_coa/status/1138372793429630977)  2019-06-11T09:09Z [---] followers, [--] engagements


"@winding_sios @ConorMcMorrow @LeoVaradkar I can guarantee you the EU will not be happy for the UK to leave. We are Europe's biggest military power we are the 2nd biggest contributor to the EU budget and our market absorbs 354Bn in EU exports. To put it in perspective that figure dwarfs the entire GDP of Ireland"  
[X Link](https://x.com/archer_coa/status/1139092931372097536)  2019-06-13T08:51Z [---] followers, [--] engagements


"Will it be via a licence deal to acquire a golden egg or will someone move to acquire the goose that lays the golden eggs If so how much will #AVCT be willing to sell their goose for To help you answer that question I have made a little thread of the major ADC deals in [----] 3/"  
[X Link](https://x.com/archer_coa/status/1737436209465397427)  2023-12-20T11:34Z [---] followers, [----] engagements


"AbbVie paid $10.1 billion cash to acquire ImmunoGen the maker of the Ovarian Cancer ADC treatment Elahere 4/"  
[X Link](https://x.com/archer_coa/status/1737436510071271477)  2023-12-20T11:35Z [---] followers, [---] engagements


"Analysts expect peak sales for the drug to reach $2 Billion by the end of the decade. The deal also included x2 clinical ADC assets in phase [--] & [--] trials respectively 5/"  
[X Link](https://x.com/archer_coa/status/1737436717236236650)  2023-12-20T11:36Z [---] followers, [---] engagements


"Bristol Myers Squibb made an $800m upfront payment to SystImmune for a phase [--] ADC candidate in a deal worth up tp $8.4 Billion. 8/"  
[X Link](https://x.com/archer_coa/status/1737437292178841625)  2023-12-20T11:38Z [---] followers, [---] engagements


"The biggest deal of the lot was Pfizers $43 Billion acquisition of Seagen /9"  
[X Link](https://x.com/archer_coa/status/1737437394268307966)  2023-12-20T11:38Z [---] followers, [---] engagements


"@GeneInvesting Excellent 😀 Its a collaboration between Neurimmune and Alexion (part of AstraZeneca)"  
[X Link](https://x.com/archer_coa/status/1743406255241085030)  2024-01-05T22:56Z [---] followers, [--] engagements


"@GeneInvesting @Ron_Witteles writes a very good thread on summarizing the NI006 trial. I believe the P3 has been enrolled so will be running at the same time as [----] 2/ (1/9) Exciting news in the #ATTR #Amyloidosis world with the publication of this Phase [--] trial of #NI006 for amyloid removal. Is this the next big thing Is it a lot of hype A 🧵. (1/9) Exciting news in the #ATTR #Amyloidosis world with the publication of this Phase [--] trial of #NI006 for amyloid removal. Is this the next big thing Is it a lot of hype A 🧵"  
[X Link](https://x.com/archer_coa/status/1743547031384121400)  2024-01-06T08:16Z [---] followers, [--] engagements


"@GeneInvesting @Ron_Witteles I just listened to your excellent Spaces with Martin Shkreli. He mentioned that Alexion was his favourite stock of all time. Its funny how its now Alexion (partner in NI006) that is now up against Inetllia in this ATTR - CM trial. You should get Martin back on again if you can"  
[X Link](https://x.com/archer_coa/status/1743548195517370440)  2024-01-06T08:20Z [---] followers, [--] engagements


"@DeepValueInv If you like #CMCX on a valuation standpoint taking into account its earnings and free cash flow you are going to love it when you read the balance sheet. Zero Debt Cash 193.1m which nearly covers all liabilities Book value of 359m vs Market Cap of 307m EV = 120m #Bargain"  
[X Link](https://x.com/anyuser/status/1744507200389669317)  2024-01-08T23:51Z [--] followers, [--] engagements


"@DeepValueInv This chart I've complied shows key figures from the balance sheet going back to [----]. No commentary required from me the chart speaks for itself #CMCX"  
[X Link](https://x.com/anyuser/status/1744511739545174318)  2024-01-09T00:09Z [--] followers, [--] engagements


"@Quality_stocksA @alexmerax ARM holdings is British not American"  
[X Link](https://x.com/archer_coa/status/1746561312459530718)  2024-01-14T15:54Z [---] followers, [---] engagements


"Alpha's conservative approach of not including interest income in their underlying numbers is hurting the shr price. Today's note from Liberum shows the value disconnect between #ALPH & WISE (who include interest income in their underlying numbers) on an apples-apples comparison"  
[X Link](https://x.com/archer_coa/status/1747946494630498771)  2024-01-18T11:38Z [---] followers, [---] engagements


"Affyxell have [--] cell therapy product candidates. AFX-001 and AFX-002. As you can see from the slide the target indication for AFX-002 is Multiple Sclerosis. Since this indication is some way off the clinic Id Im going to concentrate on AFX-001. 2/ #AVCT"  
[X Link](https://x.com/archer_coa/status/1750105192798806388)  2024-01-24T10:36Z [---] followers, [----] engagements


"It has been rumoured that AFX-001 is likely to enter the clinic this year or next. In tandem with this the Affyxell is looking to IPO. I assume this will be either on the NASDAQ or on the local Korean market (KRX). I guess Hong Kong (HKEX) could also be a possibility. 3/"  
[X Link](https://x.com/anyuser/status/1750105690822135911)  2024-01-24T10:38Z [--] followers, [---] engagements


"Dampening this abnormal donor immune response against the recipients tissues would be highly beneficial as GvHD can be a severe or even fatal post-transplant complication. 10/"  
[X Link](https://x.com/archer_coa/status/1750106827029618987)  2024-01-24T10:42Z [---] followers, [---] engagements


"So how much could Affyxell IPO for Given the cutting-edge cell/immunotherapy space tends to garner increased investor enthusiasm and the fact by the time of the IPO Affyxell should have two indications in the clinic I would expect a valuation of c. $200 - $300m. 11/ #AVCT"  
[X Link](https://x.com/archer_coa/status/1750107056281989195)  2024-01-24T10:43Z [---] followers, [----] engagements


"Its not hard to see why. Obviously we are a long way off a $14B valuation but the potential of the technology is staggering. 11/"  
[X Link](https://x.com/archer_coa/status/1755934573463015652)  2024-02-09T12:40Z [---] followers, [---] engagements


"As a holder of #AVCT stock I am a big fan of platform technologies. The Glyph prodrug platform has many similarities to Avacta's preCISION platform. It enables safer and/or more efficacious delivery of existing therapies See my blog here for more info 12/"  
[X Link](https://x.com/archer_coa/status/1755934893261894017)  2024-02-09T12:41Z [---] followers, [----] engagements


"@feynzz Word on the street is that Vedanta's Biosciences valuation as at the latest funding round was in excess of $1B. Its crazy to think that #PRTC 41% ownership in Vedanta could just about cover PureTechs entire market cap"  
[X Link](https://x.com/archer_coa/status/1766041114484642195)  2024-03-08T09:59Z [---] followers, [---] engagements


"@cousinjack1 @feynzz @Investment4Adam @cousinjack1 There is still plenty of upside here. The rerate has begun today but we are early. Read my blog for more info on why this is the case"  
[X Link](https://x.com/archer_coa/status/1770021040954999125)  2024-03-19T09:34Z [---] followers, [---] engagements


"@BarryBlockchain @unizen_io 50% savings in gas fees Are you sure Is this verfified or just a shill to get me to by the token This sounds way to good to be true. If true Im backing up the truck to buy $ZCX"  
[X Link](https://x.com/archer_coa/status/1770190306945720525)  2024-03-19T20:47Z [---] followers, [---] engagements


"@BarryBlockchain @unizen_io Have you personally communiicated with these devs to calrify how this is done Also have Unizen confirmed it"  
[X Link](https://x.com/archer_coa/status/1770192192901960041)  2024-03-19T20:54Z [---] followers, [---] engagements


"@unizen_io @BarryBlockchain Wow This is massive news. What an achievement. Once this goes live everyone in crypto will want to use your platform/tech to trade defi. When does it go live"  
[X Link](https://x.com/archer_coa/status/1770198028315464127)  2024-03-19T21:17Z [---] followers, [--] engagements


"@unizen_io @BarryBlockchain Thanks"  
[X Link](https://x.com/archer_coa/status/1770200175119663366)  2024-03-19T21:26Z [---] followers, [--] engagements


"@unizen_io Up to 50% savings on gas. Well done Unizen👏 In your example you used $18.75 as the projected $ETH gas fee. Gas fees have been much higher than this recently. Would the $ZCX gas optimization still save retail traders upto 50% when fees are much higher Im talking gas at $50-$100"  
[X Link](https://x.com/archer_coa/status/1771230570414059772)  2024-03-22T17:40Z [---] followers, [---] engagements


"@unizen_io One word: WOW 🔥 The crazy thing is literally no one knows about this. Do you realise whats going to happen to the price of $ZCX when this goes live Uniswap look out because Unizen is coming. Tick tock 🚀🚀🚀"  
[X Link](https://x.com/archer_coa/status/1771444313538359675)  2024-03-23T07:50Z [---] followers, [----] engagements


"@cryptoAZ86 @unizen_io @Sim_Berglund Thanks for taking the time to do this. As a recent investor into $ZCX I am still getting to grips with everyting thats going on at Unizen. Your video explainers have really helped me and Im getting more bullish by the day. Ive got fomo and I already own a good stack 🤣"  
[X Link](https://x.com/archer_coa/status/1773325923275739321)  2024-03-28T12:27Z [---] followers, [----] engagements


"The market has no idea that KarXT is going to be one of the biggest selling drugs in the world and little PureTech own a slice of this. This is NOT PRICED IN. Not only this#PRTC own a whole host of promising biotech assets and are currently valued at close to cash 2/2"  
[X Link](https://x.com/archer_coa/status/1839231626233978955)  2024-09-26T09:12Z [---] followers, [---] engagements


"@picker_stock @Josh44282819 @kalpjain99 On a risk v reward basis its a no brainer at current levels. https://x.com/archer_coa/status/1839258625962868927 @Josh44282819 @kalpjain99 #PRTC Current market cap is $470m ✅cash $330m ✅$400m in milestones yet to come ✅Sales royalties of $40-160m per yr from the sales of KarXT ✅pipeline of promising biotech assets at various stages of development (inc phase 3) ✅Phase [--] readout of LYT-100 in Q4 https://x.com/archer_coa/status/1839258625962868927 @Josh44282819 @kalpjain99 #PRTC Current market cap is $470m ✅cash $330m ✅$400m in milestones yet to come"  
[X Link](https://x.com/archer_coa/status/1839446596523569626)  2024-09-26T23:26Z [---] followers, [--] engagements


"@Josh44282819 @kalpjain99 Now we wait to see if this approval triggers a milestone payment for PureTech Health. I strongly suspect it will. The question is what portion of the $400m will be payable 🧐#PRTC $PRTC"  
[X Link](https://x.com/archer_coa/status/1839449031610941511)  2024-09-26T23:36Z [---] followers, [---] engagements


"@jamesallcott Liam Delap. Prediction: ⚽He will get 15+ premier league goals this season ⚽Move to a Top [--] club in the summer ⚽Start up front for England at the [----] World Cup"  
[X Link](https://x.com/archer_coa/status/1863601587240792200)  2024-12-02T15:10Z [---] followers, [---] engagements


"@BertrandBio I guess we will have to wait for the webcast to get more info on the discontinuations. However the fact that 90% of those who completed the trial opted to enroll in an ongoing open label extension suggests a positive reception of deupirfenidone among participants #PTRC"  
[X Link](https://x.com/archer_coa/status/1868574927487684901)  2024-12-16T08:32Z [---] followers, [--] engagements


"@BertrandBio I guess we will have to wait for the webcast to get more info on the discontinuations. However the fact that 90% of those who completed the trial opted to enroll in an ongoing open label extension suggests a positive reception of deupirfenidone among participants #PRTC $PRTC"  
[X Link](https://x.com/archer_coa/status/1868576197405466681)  2024-12-16T08:37Z [---] followers, [---] engagements


"@Teslanomous @daphnezohar While deupirfenidone aims for similar overall exposure (AUC) to pirfenidone the deuteration process is key. It's designed to slow the drug's breakdown potentially leading to a more stable therapeutic effect and improved tolerability even with a lower Cmax. $PRTC 1"  
[X Link](https://x.com/archer_coa/status/1869387630963781673)  2024-12-18T14:21Z [---] followers, [---] engagements


"@Teslanomous @daphnezohar While its true that some P2 results don't hold up in P3 trials the magnitude of the effect in ELEVATE with deupirfenidone 825mg approaching the lung function decline seen in healthy older adults is really promising. 3"  
[X Link](https://x.com/archer_coa/status/1869388823253450825)  2024-12-18T14:26Z [---] followers, [--] engagements


"@Teslanomous @daphnezohar In my view these are compelling results that go beyond just AUC matching. I think its highly likely we see a phase [--] trial #PRTC $PRTC #clinicaltrials #pulmonaryfibrosis 4/4"  
[X Link](https://x.com/archer_coa/status/1869389909548802160)  2024-12-18T14:31Z [---] followers, [---] engagements


"#PRTC $PRTC Excellent interview with CEO & Co Founder of PureTech Health. https://www.biotechtv.com/post/puretech-health-december-18-2024 https://www.biotechtv.com/post/puretech-health-december-18-2024"  
[X Link](https://x.com/archer_coa/status/1869774587795505293)  2024-12-19T15:59Z [---] followers, [---] engagements


"🚨 PureTech Health ($PRTC) #PRTC: A Hidden Gem in Plain Sight 💎 Is this the most mispriced stock in the UK market 🤔 Dive into the thread below and discover why the upside potential is HUGE Mega Thread 🧵👇 #biotech #undervalued #AVCT #ROQ @PureTechH"  
[X Link](https://x.com/anyuser/status/1877697987188576348)  2025-01-10T12:44Z [---] followers, [----] engagements


"🤯 $PRTC PureTech Health is WILDLY undervalued Market Cap 345m ($425m) vs. 💰$400M cash on hand (June '24). 💰Plus $373M in milestones from Royalty Pharma 💰AND future revenues from blockbuster Cobenfy (BMS paid $14B) 💰💊AND a world-class pipeline of assets. 🚀"  
[X Link](https://x.com/archer_coa/status/1877698733153874049)  2025-01-10T12:47Z [---] followers, [---] engagements


"🚀 Seaport Therapeutics is making waves Their innovative Glyph platform is designed to enhance oral bioavailability & reduce side effects of neuropsychiatric drugs. This tech could revolutionize treatments for depression anxiety & more https://seaporttx.com/our-pipeline/ https://seaporttx.com/our-pipeline/"  
[X Link](https://x.com/anyuser/status/1877699845957324807)  2025-01-10T12:51Z [---] followers, [---] engagements


"💰 $325 Million Raised Seaport has secured a total of $325 million in funding since launching in April [----] including a recently closed $225 million Series B round. This financial backing is a strong vote of confidence in their pipeline. PureTech owns 36.7% equity in Seaport"  
[X Link](https://x.com/archer_coa/status/1877700073380831516)  2025-01-10T12:52Z [---] followers, [--] engagements


"Seaport's pipeline includes SPT-300in a Phase 2b study for major depressive disorder and SPT-320 in Phase [--] for generalized anxiety disorder. The same team that developed KarXT (now Cobenfy) into a $14B drug is behind Seaport. A Nasdaq listing in the next 6-18 months is likely"  
[X Link](https://x.com/archer_coa/status/1877700302402396355)  2025-01-10T12:53Z [---] followers, [--] engagements


"🚀 Cobenfy a novel schizophrenia drug from Bristol Myers Squibb (BMS) is a game-changer It's the first new type of schizophrenia drug approved in over [--] years. PureTech is set to receive up to $400M in milestone payments from Royalty Pharma. This is just the beginning"  
[X Link](https://x.com/archer_coa/status/1877700705563160885)  2025-01-10T12:55Z [---] followers, [---] engagements


"The market just got a lot clearer for Cobenfy AbbVie'srival drug emraclidine failed in Phase [--] trials. This failure has sent BMS stock up 11% and solidifies Cobenfy as the "sole muscarinic winner". With peak sales projected at $10B+ annually by Jeffries analysts this is big"  
[X Link](https://x.com/archer_coa/status/1877700934148436066)  2025-01-10T12:56Z [---] followers, [---] engagements


"https://finance.yahoo.com/news/jefferies-upgrades-bristol-myers-squibb-174803215.html https://finance.yahoo.com/news/jefferies-upgrades-bristol-myers-squibb-174803215.html"  
[X Link](https://x.com/archer_coa/status/1877700963718336894)  2025-01-10T12:56Z [---] followers, [--] engagements


"🚀 LYT-200 is being evaluated in Phase 1/2 trials for AML/MDS and head & neck cancers with FDA Fast Track designation for both (announced yesterday) https://news.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-lyt-200-anti-galectin-9-monoclonal https://news.puretechhealth.com/news-releases/news-release-details/puretech-presents-data-lyt-200-anti-galectin-9-monoclonal"  
[X Link](https://x.com/archer_coa/status/1877702732120772880)  2025-01-10T13:03Z [---] followers, [--] engagements


"🔬 Vedanta Biosciencesis pioneering microbiome drugs with PureTech owning 35.9% They've raised over $177M across Series C & D with backing from the Bill & Melinda Gates Foundation. Their unique approach could transform treatments for diseases like C. diff and IBD"  
[X Link](https://x.com/archer_coa/status/1877702852891570278)  2025-01-10T13:03Z [---] followers, [--] engagements


"Their 36.7% stake in Seaport alone may be worth more than half of their market cap"  
[X Link](https://x.com/archer_coa/status/1877703820240715967)  2025-01-10T13:07Z [---] followers, [--] engagements


"🤔 The market cap of #PRTC is a complete nonsense given the $400M cash the potential for hundreds of millions in milestone payments a large stake in Seaport and multiple late-stage assets poised to be blockbusters if successful in phase [--]. Someone please make this make sense"  
[X Link](https://x.com/archer_coa/status/1877704001686323530)  2025-01-10T13:08Z [---] followers, [---] engagements


"🚀 PureTech Health'sgroundbreaking "hub & spoke" model is powered by a world-class board & deep bench of scientific & industry leaders. They've driven the development of [--] therapeutics & therapeutic candidates incl. [--] FDA approvals and multi-billion dollar transactions"  
[X Link](https://x.com/archer_coa/status/1877704456206180832)  2025-01-10T13:10Z [---] followers, [---] engagements


"Alpha Group knock it out the park again despite tough trading conditions 🔺Revenue on underlying activities up 23% 🔺Total income (inc interest income) up 18% to 221m 🔺Net cash increased by 40m to 217m 🚀PE [--] for a high quality growth business is a joke #ALPH"  
[X Link](https://x.com/anyuser/status/1881618591394771245)  2025-01-21T08:23Z [---] followers, [---] engagements


"UK biotech investors can you find me a more undervalued biotech stock than PureTech Health My view - its wildly undervalued. Take a look over the slides below and tell me if Im right. How much do you think #PRTC is worth #AVCT #OBX #HVO #PRTC #AZN"  
[X Link](https://x.com/anyuser/status/1881674560439042242)  2025-01-21T12:05Z [---] followers, [----] engagements


"@CapitalPmh I know you invest in Biotech. Check out PureTech health and tell me its not wildly undervalued. It has its market cap in cash with plenty more cash to come in this year via milestones. World class pipeline. Would love to hear your thoughts🙏 https://x.com/archer_coa/status/1881674560439042242 UK biotech investors can you find me a more undervalued biotech stock than PureTech Health My view - its wildly undervalued. Take a look over the slides below and tell me if Im right. How much do you think #PRTC is worth #AVCT #OBX #HVO #PRTC #AZN https://t.co/Nu45e4RboH"  
[X Link](https://x.com/archer_coa/status/1881679073392705946)  2025-01-21T12:23Z [---] followers, [--] engagements


"@GaryNTrader @DonaldPond6 @RebelHQ Was he being held on remand while he waited for his trial I doubt it. Yet all those who were charged with incitement becuase of social media posts were banged up on remand and told their trial dates were 9+ months away. They were strong armed into pleading guilty"  
[X Link](https://x.com/archer_coa/status/1882361671722865121)  2025-01-23T09:36Z [---] followers, [--] engagements


"@SeanDentBsc @PMac295 Stop being so precious. There are other stocks out there you know. I've been in Avacta since [----] so know the stock as well as anyone FYI #PRTC also have a cancer drug. Phase 1b data so far: [--] patients 80% response rate [--] complete responses [--] patient declared Leukemia free"  
[X Link](https://x.com/archer_coa/status/1882518176732422647)  2025-01-23T19:58Z [---] followers, [---] engagements


"@SeanDentBsc @PMac295 PureTech own a sizeable stake in Cobenfy. JP Morgan analyst Chris Schott expects peak sales in the $10 Billion range. This equates to c. $160m per annum at peak sales for PureTech. #PRTC recieve a 2% royalty on all sales of Cobenfy $2B"  
[X Link](https://x.com/archer_coa/status/1882552802029044148)  2025-01-23T22:15Z [---] followers, [---] engagements


"@SeanDentBsc @PMac295 Cobenfy is going to be one of the biggest selling drugs in the world. No wonder Bristol Myers were prepared to pay $14 Billion for it. PureTech developed the drug and still own a decent chunk of it 🚀 $PRTC https://www.cnbc.com/amp/2025/01/15/bristol-myers-squibb-schizophrenia-drug-cobenfy-could-treat-alzheimers.html https://www.cnbc.com/amp/2025/01/15/bristol-myers-squibb-schizophrenia-drug-cobenfy-could-treat-alzheimers.html"  
[X Link](https://x.com/archer_coa/status/1882553440397902008)  2025-01-23T22:18Z [---] followers, [---] engagements


"@patviera Sorry i meant $BMY (Bristol Myers Squibb)"  
[X Link](https://x.com/archer_coa/status/1882748300287508804)  2025-01-24T11:12Z [---] followers, [---] engagements


"@MrFunnyFace @PureTechH It is actually listed on NASDAQ but unfortunately there is very little liquidity on that exchange so the vast majority of the volume is done in London. UK broker targets as follows: Jefferies [----] Peel Hunt 5.08"  
[X Link](https://x.com/archer_coa/status/1882891806863704482)  2025-01-24T20:42Z [---] followers, [--] engagements


"@MGinvestor Cobenfy is going to be one of the biggest selling drugs in the world. No wonder Bristol Myers were prepared to pay $14 Billion for it. https://www.cnbc.com/amp/2025/01/15/bristol-myers-squibb-schizophrenia-drug-cobenfy-could-treat-alzheimers.html https://www.cnbc.com/amp/2025/01/15/bristol-myers-squibb-schizophrenia-drug-cobenfy-could-treat-alzheimers.html"  
[X Link](https://x.com/archer_coa/status/1884619133783863460)  2025-01-29T15:06Z [---] followers, [--] engagements


"@MGinvestor JP Morgan analyst Chris Schott expects sales of Cobenfy to be $5 billion by [----] = $60m in royalities for PRTC. Peak sales forecast to be 10B = $160m pa for PRTC. PRTC recieve a 2% royalty on all sales of Cobenfy $2B"  
[X Link](https://x.com/archer_coa/status/1884620690814329075)  2025-01-29T15:12Z [---] followers, [--] engagements


"@MGinvestor Stock is trading at cash so at today's price you are essentially buying the company for free plus you get a top-tier clinical pipeline & a major stake in Cobenfy which BMY recently snagged for $14B. Ask away"  
[X Link](https://x.com/archer_coa/status/1884623309402235330)  2025-01-29T15:23Z [---] followers, [---] engagements


"@MGinvestor Witha vast array of drugs in clinical trials we're looking at numerous catalysts this year from trial results. Also expect updates on $BMY's Cobenfy sales plus one or two milestone payments that'll boost our already substantial cash reserves with $373M in milestones still due"  
[X Link](https://x.com/archer_coa/status/1884626433730850978)  2025-01-29T15:35Z [---] followers, [---] engagements


"@PETERMINIHAN @beshoefree The board at #PRTC believes that Seaport's Glyph platform has the potential to be more lucrative than Cobenfy. It's no surprise that Daphne Zohar is now at the helm of Seaport. Her M.D. is Steven Paul M.D. the former CEO of Karuna which was acquired by $BMY for $14B"  
[X Link](https://x.com/archer_coa/status/1884934008271761879)  2025-01-30T11:57Z [---] followers, [---] engagements


"Beyond the $100Ms in milestones and royalties yet to come from PureTech's sizeable stake in Cobenfy ($BMY's $14B schizophrenia drug) PureTech's pipeline looks very promising with plenty of value drivers in the next few years. Here's a snapshot: #PRTC $PRTC"  
[X Link](https://x.com/archer_coa/status/1885277345818275865)  2025-01-31T10:42Z [---] followers, [---] engagements


"@qualitycompound All options should be considered. A raise keeps LYT100 in house. If approved the drug will be worth $multi billions. It convincingly beat Pirfenidone (soc) in a head to head P2B trial. Roche paid $8.3B for Pirfenidone in [----]. If P3 is replicated LYT100 is worth $Billions"  
[X Link](https://x.com/archer_coa/status/1885295971984121896)  2025-01-31T11:56Z [---] followers, [--] engagements


"@GeneInvesting PureTech Health(PRTC) 🚀Trading at near cash: $365 vs $390 market cap 🚀Large pipeline of clinical assets 🚀Mulitple potential blockbuster drugs in p3 🚀Near term future cash flows via significant ownership stake in Cobenfy (1st FDA approved schizophrenia drug in [--] yrs)"  
[X Link](https://x.com/archer_coa/status/1905216020861653004)  2025-03-27T11:11Z [---] followers, [---] engagements


"@GeneInvesting PRTC also owns 100% of LYT200 (immunotherapy with orphan drug + FDA fast track). Their crown jewel The Glyph platform. Ex-Karuna CEO who sold it to BMY for $14B now co-leads Seaport betting itll outshine Karuna. https://seaporttx.com/our-pipeline/ https://seaporttx.com/our-pipeline/"  
[X Link](https://x.com/archer_coa/status/1905280286486597650)  2025-03-27T15:26Z [---] followers, [--] engagements


"@seedy19tron The Tyvaso data for IPF as an add-on therapy to antifibrotics is really promising @seedy19tron what are your thoughts on $UTHR's ODD 7yr exclusivity impact on $LQDA's YUTREPIA Off-label use possible And does this ODE effectively block L606 in IPF"  
[X Link](https://x.com/archer_coa/status/1965752276389372277)  2025-09-10T12:20Z [---] followers, [----] engagements


"@bharringtonw11 🔺Pipeline Catalysts:LYT-100: Phase 3-ready for IPF (deadly lung disease) trial launch H1 [----]. 🔺LYT-200: Phase 1b immuno-oncology for AML/MDS data Q4 [----]. 2/5"  
[X Link](https://x.com/archer_coa/status/1969108310994358516)  2025-09-19T18:36Z [---] followers, [--] engagements


"@bharringtonw11 🔺35% Stake in Seaport Therapeutics: Fresh off $225M Series B (Oct 2024) for neuropsych pipeline GlyphAgo (GAD) Phase [--] underway. 3/5"  
[X Link](https://x.com/archer_coa/status/1969109014681137405)  2025-09-19T18:39Z [---] followers, [--] engagements


"🚨Spruce Biosciences $SPRB Find out why this late stage orphan play looks absurdly priced. Market is sleeping on the potential here. [--] bagger potential🚀 Don't miss this one🔥 Read my full thesis here: https://open.substack.com/pub/mrchrisarcher/p/spruce-biosciences-sprb-a-late-stager=50c78&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true https://open.substack.com/pub/mrchrisarcher/p/spruce-biosciences-sprb-a-late-stager=50c78&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true"  
[X Link](https://x.com/anyuser/status/2010725812648206757)  2026-01-12T14:49Z [---] followers, [----] engagements


"$PRTC https://mrchrisarcher.substack.com/p/puretech-health-prtc-a-rarely-mispriced https://mrchrisarcher.substack.com/p/puretech-health-prtc-a-rarely-mispriced"  
[X Link](https://x.com/anyuser/status/2011024464880763116)  2026-01-13T10:36Z [---] followers, [---] engagements


"$JAZZ sold their PRV for $200M - insane value in this market 🤑🤪🤯(see screenshot from $JAZZ recent investor presentation) Massive read-across to $SPRB Spruce Biosciences (mkt cap $85M): On track for Q1 [----] BLA submission good chance of receiving the PRV in Q3 [----] (if approved before Sept [--] sunset). Could be a game-changing non-dilutive windfall. 💰 Spruce Bio's market cap less than half a possible payout. 🚀 Why the setup looks strong check this: https://mrchrisarcher.substack.com/p/spruce-biosciences-sprb-a-late-stage"  
[X Link](https://x.com/anyuser/status/2011372989019738572)  2026-01-14T09:41Z [---] followers, [----] engagements


"@SarahLeeNotCake @ConorMcMorrow @LeoVaradkar The EU need to renegotiate because a no deal would be a disaster for them as well as us. Trust me they want a partnership with Europe's leading defence and military power and they don't want to let go unfettered access to our market that absorbs 395bn of EU exports"  
[X Link](https://x.com/archer_coa/status/1138478106782646275)  2019-06-11T16:08Z [---] followers, [--] engagements


"Gracell Biotechnologies recently acquired by AstraZeneca $1.2BILLION https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-to-acquire-gracell-furthering-cell-therapy-ambition-across-oncology-and-autoimmune-diseases.html https://www.astrazeneca.com/media-centre/press-releases/2023/astrazeneca-to-acquire-gracell-furthering-cell-therapy-ambition-across-oncology-and-autoimmune-diseases.html"  
[X Link](https://x.com/archer_coa/status/1750108084083585142)  2024-01-24T10:47Z [---] followers, [---] engagements


"@MartinGranstrom @unizen_io Question is how does $ZCX stack up agianst Uniswap & [--] inch in terms of cost. $ZCX claim the gas optimizations will save 40-50% on gas fees. To be clear once the gas optimizations are live does this mean trading on Unizen will be 40-50% less expensive than Uniswap and [--] Inch"  
[X Link](https://x.com/archer_coa/status/1775225910226038933)  2024-04-02T18:16Z [---] followers, [---] engagements


"@unizen_io 1inch claim to give users upto 40% savings on gas fees. After the optimizations will gas fees on Unizen be significantly cheaper than 1inch"  
[X Link](https://x.com/archer_coa/status/1775836440217194584)  2024-04-04T10:42Z [---] followers, [---] engagements


"The FDA will approve $BMY owned KarXT today. FDA apporval should trigger a milestone payment for PureTech Health (due $400m in milestones). In addition #PRTC $PTRC will recieve a 2% royalty on all sales $2B. Analysts predict peak sales of $10B = $160m in royalities. 1/2"  
[X Link](https://x.com/archer_coa/status/1839229748410487058)  2024-09-26T09:05Z [---] followers, [----] engagements


"@bharringtonw11 Why Tang Capital is betting big on PureTech $PRTC: A biotech undervalued at current levels. Here's the thesis in a nutshell: 🔺Fortress Balance Sheet: $320M cash & equivalents (H1 2025) runway to [----] no dilution dilution risk. 🧵 1/5"  
[X Link](https://x.com/archer_coa/status/1969107770122064188)  2025-09-19T18:34Z [---] followers, [---] engagements


"@bharringtonw11 🔺Royalty Windfall: 2% on Cobenfy (BMS blockbuster for schizophrenia) sales over $2B annually early revenues already flowing post-FDA approval. 4/5"  
[X Link](https://x.com/archer_coa/status/1969109281115959485)  2025-09-19T18:40Z [---] followers, [---] engagements


"@bharringtonw11 Tangs play is clear: with Nordic Capitals failed bid signaling M&A interest #PRTCs cash pipeline and Seaport stake make it a prime target for a buyout or private equity sale or a piecemeal asset spin-off to return cash to investors. 👀 Current Market Cap $398m 5/5"  
[X Link](https://x.com/archer_coa/status/1969110816445092173)  2025-09-19T18:46Z [---] followers, [---] engagements


"🚨"Avacta currently leading the way in dual-payload PDCs" New must-read article just dropped naming #AVCT as the frontrunner in the hottest new ADC/PDC wave: dual-warheads designed to kill resistance dead. https://www.labiotech.eu/in-depth/dual-payload-adcs-pdcs/ https://www.labiotech.eu/in-depth/dual-payload-adcs-pdcs/"  
[X Link](https://x.com/anyuser/status/1991479816009445701)  2025-11-20T12:12Z [---] followers, [----] engagements


"Respect the contrarian $UBER take (always sharpens the debate) but I disagree. Jensen Huang was explicit: Nvidia's vision is "every single car every single truck" becoming autonomous powered by open platforms like Alpamayo that any OEM/developer can plug into cheaply and quickly. This isn't proprietary moat-building it's picks-and-shovels commoditization lowering barriers dramatically. Result Expect dozens of players. These fragmented fleets will desperately need a neutral liquid marketplace for demand Uber's 150M+ MAUs routing magic and predictive algorithms provide unmatched utilization."  
[X Link](https://x.com/archer_coa/status/2010292527203496245)  2026-01-11T10:07Z [---] followers, [---] engagements


"Rose concentration in those dense cities actually protects $uber more than it exposes them. It's a moat not a vulnerability. These are the hardest markets to crack: heavy regs politics and operational complexity. No one - not even Tesla - can muscle in fast or cheaply. This concentration is Uber's strength. https://twitter.com/i/web/status/2010351968921731488 https://twitter.com/i/web/status/2010351968921731488"  
[X Link](https://x.com/archer_coa/status/2010351968921731488)  2026-01-11T14:03Z [---] followers, [---] engagements


"Waymo spent over a decade + billions to reach 27% share in SF. Even in the so-called easiest dense city Uber remains dominant. So much so that Waymo abandoned a solo model - in Austin and Atlanta they operate exclusively through $Uber. SF proves AVs are a tailwind not a threat for Ubers platform. https://twitter.com/i/web/status/2010364104322564201 https://twitter.com/i/web/status/2010364104322564201"  
[X Link](https://x.com/archer_coa/status/2010364104322564201)  2026-01-11T14:52Z [---] followers, [---] engagements


"@realroseceline You might want to let Uber investors know official Uber and Waymo literature clearly states that in Austin & Atlanta Waymo rides are available only on the Uber app. Check for yourself: https://waymo.com/waymo-on-uber/ https://investor.uber.com/news-events/news/press-release-details/2024/Uber-and-Waymo-Expand-Partnership-to-Bring-Autonomous-Ride-Hailing-to-Austin-and-Atlanta/default.aspxpubDate=20250415&utm_source=chatgpt.com https://waymo.com/waymo-on-uber/"  
[X Link](https://x.com/archer_coa/status/2010383865786024037)  2026-01-11T16:10Z [---] followers, [--] engagements


"@Reset121125 @jlucer53 @EmuConspiracy Sanders blocked the standalone in Dec to bundle his health center priorities but now it's all in the minibus package. Sanders shouldnt block it now hes got what he wants. 🤞"  
[X Link](https://x.com/archer_coa/status/2014304913044488594)  2026-01-22T11:51Z [---] followers, [---] engagements


"Looks like the market is finally waking up to the undeniable value on offer at $DAWN https://substack.com/@mrchrisarcher/note/p-184710915r=50c78&utm_source=notes-share-action&utm_medium=web https://substack.com/@mrchrisarcher/note/p-184710915r=50c78&utm_source=notes-share-action&utm_medium=web"  
[X Link](https://x.com/anyuser/status/2013648553399243023)  2026-01-20T16:23Z [---] followers, [---] engagements


"@Reset121125 @jlucer53 @EmuConspiracy If this minibus vote goes through those old expiration dates become irrelevant - no more time pressure on the PRV reauth. Massive tailwind unlocked for pediatric rare disease biotech. Great news for $SPRB when it clears (likely soon) #GiveKidsAChance"  
[X Link](https://x.com/archer_coa/status/2014298579930591455)  2026-01-22T11:26Z [---] followers, [---] engagements


"@GeneInvesting Great news for $CRSP & $VRTX also great news for $MXCT. Maxcyte will be taking a low to mid single digit royalty on all sales for CASGEVY going forward. Same deal goes for all those companies who have signed Strategic Platform Licences with Maxcyte inc $BEAM"  
[X Link](https://x.com/archer_coa/status/1744810645814440426)  2024-01-09T19:57Z [---] followers, [---] engagements


"@seedy19tron Thanks for sharing your $SLNO thesis. I really enjoyed the deep dive. Price action may be tough right now but I'm confident you'll be vindicated in the end. You inspired me to launch my own biotech-focused Substack. This month I've written up two opportunities I see as interesting asymmetric setups right now: $PRTC and $SPRB Check them out if you get a minute: Appreciate your takes. keep crushing it 🚀 https://open.substack.com/pub/mrchrisarcher/p/spruce-biosciences-sprb-a-late-stageutm_campaign=post-expanded-share&utm_medium=web"  
[X Link](https://x.com/archer_coa/status/2011006132639158487)  2026-01-13T09:23Z [---] followers, [---] engagements


"$DAWN (Day One Biopharmaceuticals) is seriously mispriced. Check out my full deep dive on Substack for the why - it's a compelling setup 🚀 https://open.substack.com/pub/mrchrisarcher/p/day-one-biopharmaceuticals-dawn-autm_campaign=post-expanded-share&utm_medium=web https://open.substack.com/pub/mrchrisarcher/p/day-one-biopharmaceuticals-dawn-autm_campaign=post-expanded-share&utm_medium=web"  
[X Link](https://x.com/anyuser/status/2012122972442784133)  2026-01-16T11:21Z [---] followers, [----] engagements


"If the early patient data is stellar then this valuation could be a lot higher (the reverse is also true). The $200- $300m is based on the following comparables of recent US-listed cell therapy companies in stage [--] clinical development. 12/ #AVCT"  
[X Link](https://x.com/archer_coa/status/1750107531530190867)  2024-01-24T10:45Z [---] followers, [----] engagements


"@patviera @patviera would love your take on PureTech 💰330m mcap 💰$365m cash 💰No Debt 🚀Sizeable stake in Cobenfy (schizophrenia drug $BMS paid $14 Billion for) 🚀PRTC will receive $100s of millions from Cobenfy in milestones and royalties 🚀Drugs in pipeline: x2 p3 x2 p2 x2 p1"  
[X Link](https://x.com/archer_coa/status/1882747454518682071)  2025-01-24T11:09Z [---] followers, [---] engagements


"🚨 First Substack drop $PRTC.L #PRTC PureTech Health 💰Cash runway to 2028+ portfolio of [--] mid & late stage multi-bn dollar assets priced at ZERO. 🚀Why this biotech disconnect screams opportunity: #biotech @SeaportTx @daphnezohar @PureTechH https://open.substack.com/pub/mrchrisarcher/p/puretech-health-prtc-a-rarely-mispricedr=50c78&utm_campaign=post&utm_medium=web https://open.substack.com/pub/mrchrisarcher/p/puretech-health-prtc-a-rarely-mispricedr=50c78&utm_campaign=post&utm_medium=web"  
[X Link](https://x.com/anyuser/status/2009242413630689319)  2026-01-08T12:34Z [---] followers, [---] engagements


"$SPRB https://www.businesswire.com/news/home/20260128573673/en/Spruce-Biosciences-Announces-Data-Presentations-at-the-22nd-Annual-WORLDSymposium https://www.businesswire.com/news/home/20260128573673/en/Spruce-Biosciences-Announces-Data-Presentations-at-the-22nd-Annual-WORLDSymposium"  
[X Link](https://x.com/anyuser/status/2016497983680823484)  2026-01-28T13:05Z [---] followers, [---] engagements


"Massive news for $SPRB 🚀 https://x.com/PRVWatch/status/2018785618386731456s=20 The House has passed the bill to extend the rare pediatric disease priority review voucher program to [----]. The bill is now on the Presidents desk to be signed into Law. Amazing news for patients and the industry. https://t.co/5OYsg0wJzI https://x.com/PRVWatch/status/2018785618386731456s=20 The House has passed the bill to extend the rare pediatric disease priority review voucher program to [----]. The bill is now on the Presidents desk to be signed into Law. Amazing news for patients and the industry."  
[X Link](https://x.com/anyuser/status/2018788541103566930)  2026-02-03T20:47Z [---] followers, [----] engagements


"If you don't know why this news is transformative for Spruce Biosciences then read my article: https://x.com/archer_coa/status/2016497983680823484s=20 $SPRB https://t.co/WsMd94xQGM https://x.com/archer_coa/status/2016497983680823484s=20 $SPRB https://t.co/WsMd94xQGM"  
[X Link](https://x.com/anyuser/status/2018789418472222929)  2026-02-03T20:51Z [---] followers, [---] engagements


"🚨 First Substack drop $PRTC.L #PRTC PureTech Health 💰Cash runway to 2028+ portfolio of [--] mid & late stage multi-bn dollar assets priced at ZERO. 🚀Why this biotech disconnect screams opportunity: #biotech @SeaportTx @daphnezohar @PureTechH https://open.substack.com/pub/mrchrisarcher/p/puretech-health-prtc-a-rarely-mispricedr=50c78&utm_campaign=post&utm_medium=web https://open.substack.com/pub/mrchrisarcher/p/puretech-health-prtc-a-rarely-mispricedr=50c78&utm_campaign=post&utm_medium=web"  
[X Link](https://x.com/anyuser/status/2009242413630689319)  2026-01-08T12:34Z [---] followers, [---] engagements


"Massive news for $SPRB 🚀 https://x.com/PRVWatch/status/2018785618386731456s=20 The House has passed the bill to extend the rare pediatric disease priority review voucher program to [----]. The bill is now on the Presidents desk to be signed into Law. Amazing news for patients and the industry. https://t.co/5OYsg0wJzI https://x.com/PRVWatch/status/2018785618386731456s=20 The House has passed the bill to extend the rare pediatric disease priority review voucher program to [----]. The bill is now on the Presidents desk to be signed into Law. Amazing news for patients and the industry."  
[X Link](https://x.com/anyuser/status/2018788541103566930)  2026-02-03T20:47Z [---] followers, [----] engagements


"The House has passed the bill to extend the rare pediatric disease priority review voucher program to [----]. The bill is now on the Presidents desk to be signed into Law. Amazing news for patients and the industry"  
[X Link](https://x.com/anyuser/status/2018785618386731456)  2026-02-03T20:36Z [---] followers, [----] engagements


"If you don't know why this news is transformative for Spruce Biosciences then read my article: https://x.com/archer_coa/status/2016497983680823484s=20 $SPRB https://t.co/WsMd94xQGM https://x.com/archer_coa/status/2016497983680823484s=20 $SPRB https://t.co/WsMd94xQGM"  
[X Link](https://x.com/anyuser/status/2018789418472222929)  2026-02-03T20:51Z [---] followers, [---] engagements


"$SPRB https://www.businesswire.com/news/home/20260128573673/en/Spruce-Biosciences-Announces-Data-Presentations-at-the-22nd-Annual-WORLDSymposium https://www.businesswire.com/news/home/20260128573673/en/Spruce-Biosciences-Announces-Data-Presentations-at-the-22nd-Annual-WORLDSymposium"  
[X Link](https://x.com/anyuser/status/2016497983680823484)  2026-01-28T13:05Z [---] followers, [---] engagements


"Looks like the market is finally waking up to the undeniable value on offer at $DAWN https://substack.com/@mrchrisarcher/note/p-184710915r=50c78&utm_source=notes-share-action&utm_medium=web https://substack.com/@mrchrisarcher/note/p-184710915r=50c78&utm_source=notes-share-action&utm_medium=web"  
[X Link](https://x.com/anyuser/status/2013648553399243023)  2026-01-20T16:23Z [---] followers, [---] engagements


"$DAWN (Day One Biopharmaceuticals) is seriously mispriced. Check out my full deep dive on Substack for the why - it's a compelling setup 🚀 https://open.substack.com/pub/mrchrisarcher/p/day-one-biopharmaceuticals-dawn-autm_campaign=post-expanded-share&utm_medium=web https://open.substack.com/pub/mrchrisarcher/p/day-one-biopharmaceuticals-dawn-autm_campaign=post-expanded-share&utm_medium=web"  
[X Link](https://x.com/anyuser/status/2012122972442784133)  2026-01-16T11:21Z [---] followers, [----] engagements


"Hi 👋 I've started a free to read Substack to write about interesting asymmetric opportunities I spot in the markets (heavy on biotech for now). So far I've covered two under-the-radar setups that look well-positioned for [----]. Click the link to find out more: #PRTC $SPRB #AVCT $AZN #GSK #HVO #POLB https://mrchrisarcher.substack.com https://mrchrisarcher.substack.com"  
[X Link](https://x.com/anyuser/status/2011396933915484391)  2026-01-14T11:16Z [---] followers, [---] engagements


"$JAZZ sold their PRV for $200M - insane value in this market 🤑🤪🤯(see screenshot from $JAZZ recent investor presentation) Massive read-across to $SPRB Spruce Biosciences (mkt cap $85M): On track for Q1 [----] BLA submission good chance of receiving the PRV in Q3 [----] (if approved before Sept [--] sunset). Could be a game-changing non-dilutive windfall. 💰 Spruce Bio's market cap less than half a possible payout. 🚀 Why the setup looks strong check this: https://mrchrisarcher.substack.com/p/spruce-biosciences-sprb-a-late-stage"  
[X Link](https://x.com/anyuser/status/2011372989019738572)  2026-01-14T09:41Z [---] followers, [----] engagements


"Thanks to @PRVWatch for the heads up 🙏 https://x.com/PRVWatch/status/2011206056534319206s=20 Evolution of Priority Review Voucher sales in the last year: Q1 '25: $150M Q2 '25: $155M $160M (+1 undisclosed sale price) Q3 '25: $175M Q4 '25: none reported Q1 '26: $200M https://x.com/PRVWatch/status/2011206056534319206s=20 Evolution of Priority Review Voucher sales in the last year: Q1 '25: $150M Q2 '25: $155M $160M (+1 undisclosed sale price) Q3 '25: $175M Q4 '25: none reported Q1 '26: $200M"  
[X Link](https://x.com/anyuser/status/2011375648728862740)  2026-01-14T09:51Z [---] followers, [---] engagements


"Evolution of Priority Review Voucher sales in the last year: Q1 '25: $150M Q2 '25: $155M $160M (+1 undisclosed sale price) Q3 '25: $175M Q4 '25: none reported Q1 '26: $200M"  
[X Link](https://x.com/anyuser/status/2011206056534319206)  2026-01-13T22:37Z [---] followers, [----] engagements


"$PRTC https://mrchrisarcher.substack.com/p/puretech-health-prtc-a-rarely-mispriced https://mrchrisarcher.substack.com/p/puretech-health-prtc-a-rarely-mispriced"  
[X Link](https://x.com/anyuser/status/2011024464880763116)  2026-01-13T10:36Z [---] followers, [---] engagements


"🚨Spruce Biosciences $SPRB Find out why this late stage orphan play looks absurdly priced. Market is sleeping on the potential here. [--] bagger potential🚀 Don't miss this one🔥 Read my full thesis here: https://open.substack.com/pub/mrchrisarcher/p/spruce-biosciences-sprb-a-late-stager=50c78&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true https://open.substack.com/pub/mrchrisarcher/p/spruce-biosciences-sprb-a-late-stager=50c78&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true"  
[X Link](https://x.com/anyuser/status/2010725812648206757)  2026-01-12T14:49Z [---] followers, [----] engagements


"🚨"Avacta currently leading the way in dual-payload PDCs" New must-read article just dropped naming #AVCT as the frontrunner in the hottest new ADC/PDC wave: dual-warheads designed to kill resistance dead. https://www.labiotech.eu/in-depth/dual-payload-adcs-pdcs/ https://www.labiotech.eu/in-depth/dual-payload-adcs-pdcs/"  
[X Link](https://x.com/anyuser/status/1991479816009445701)  2025-11-20T12:12Z [---] followers, [----] engagements


"UK biotech investors can you find me a more undervalued biotech stock than PureTech Health My view - its wildly undervalued. Take a look over the slides below and tell me if Im right. How much do you think #PRTC is worth #AVCT #OBX #HVO #PRTC #AZN"  
[X Link](https://x.com/anyuser/status/1881674560439042242)  2025-01-21T12:05Z [---] followers, [----] engagements


"Oh and by the way PRTC is currently trading at near cash so you effectively get their stake in Cobenfy (launched on the market last year & forecast to be one of the biggest selling drugs in the world)plus their entire pipeline for free. Please find me a more undervalued biotech"  
[X Link](https://x.com/anyuser/status/1885279226363789543)  2025-01-31T10:49Z [---] followers, [---] engagements


"The market has no idea PRTC own a decent size stake in Cobenfy. "Cobenfy possibly the biggest drug of our generation" - Jim Cramer "One new potential indication or data readout on Cobenfy every year for the rest of the decade" - CEO Brsitol Myers https://www.youtube.com/watchv=ZL30ISQ5R8U https://www.youtube.com/watchv=ZL30ISQ5R8U"  
[X Link](https://x.com/anyuser/status/1899399459353608210)  2025-03-11T09:58Z [---] followers, [---] engagements


"PureTech Health #PRTC Not only are you buying a fundamentally criminally undervalued stock you are also buying at a historically low price. For those who like technical analysis we are currently sitting on an area of mega demand. This level has not been breached since 2017"  
[X Link](https://x.com/anyuser/status/1885314042773840235)  2025-01-31T13:07Z [---] followers, [---] engagements


"Alpha Group knock it out the park again despite tough trading conditions 🔺Revenue on underlying activities up 23% 🔺Total income (inc interest income) up 18% to 221m 🔺Net cash increased by 40m to 217m 🚀PE [--] for a high quality growth business is a joke #ALPH"  
[X Link](https://x.com/anyuser/status/1881618591394771245)  2025-01-21T08:23Z [---] followers, [---] engagements


"🚨 PureTech Health ($PRTC) #PRTC: A Hidden Gem in Plain Sight 💎 Is this the most mispriced stock in the UK market 🤔 Dive into the thread below and discover why the upside potential is HUGE Mega Thread 🧵👇 #biotech #undervalued #AVCT #ROQ @PureTechH"  
[X Link](https://x.com/anyuser/status/1877697987188576348)  2025-01-10T12:44Z [---] followers, [----] engagements


"https://www.vedantabio.com/ https://www.vedantabio.com/"  
[X Link](https://x.com/anyuser/status/1877702999272771995)  2025-01-10T13:04Z [---] followers, [---] engagements


"https://x.com/archer_coa/status/1877703534302449997 PureTechs pipeline including late-stage assets like LYT-100 (IPF) and Vedanta (microbiome) is incredibly promising. Not to mention LYT-200 an immunotherapy showing complete responses in Phase [--]. https://x.com/archer_coa/status/1877703534302449997 PureTechs pipeline including late-stage assets like LYT-100 (IPF) and Vedanta (microbiome) is incredibly promising. Not to mention LYT-200 an immunotherapy showing complete responses in Phase 1"  
[X Link](https://x.com/anyuser/status/1877705751059198180)  2025-01-10T13:15Z [---] followers, [---] engagements


"PureTechs pipeline including late-stage assets like LYT-100 (IPF) and Vedanta (microbiome) is incredibly promising. Not to mention LYT-200 an immunotherapy showing complete responses in Phase 1"  
[X Link](https://x.com/anyuser/status/1877703534302449997)  2025-01-10T13:06Z [---] followers, [---] engagements


"How will PureTech fund the crucial Ph3 trial for LYT-100 Options include: 🔺go it alone using their massive cash reserves 🔺 a potential Nasdaq raise with specialist US healthcare investors 🔺 partnering All options on the table https://www.biotechtv.com/post/puretech-health-december-18-2024 https://www.biotechtv.com/post/puretech-health-december-18-2024"  
[X Link](https://x.com/anyuser/status/1877699646719467931)  2025-01-10T12:50Z [---] followers, [---] engagements


"https://x.com/archer_coa/status/1877699845957324807 🚀 Seaport Therapeutics is making waves Their innovative Glyph platform is designed to enhance oral bioavailability & reduce side effects of neuropsychiatric drugs. This tech could revolutionize treatments for depression anxiety & more https://t.co/lv28ZOrpvk https://x.com/archer_coa/status/1877699845957324807 🚀 Seaport Therapeutics is making waves Their innovative Glyph platform is designed to enhance oral bioavailability & reduce side effects of neuropsychiatric drugs. This tech could revolutionize treatments for depression anxiety & more"  
[X Link](https://x.com/anyuser/status/1877705475023646917)  2025-01-10T13:14Z [---] followers, [---] engagements


"🚀 Seaport Therapeutics is making waves Their innovative Glyph platform is designed to enhance oral bioavailability & reduce side effects of neuropsychiatric drugs. This tech could revolutionize treatments for depression anxiety & more https://seaporttx.com/our-pipeline/ https://seaporttx.com/our-pipeline/"  
[X Link](https://x.com/anyuser/status/1877699845957324807)  2025-01-10T12:51Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing